Improving olaparib exposure to optimize adverse effects management.

Marylise SterléAlicja PuszkielChloé BurlotEva PereiraAudrey BellesoeurSixtine De PercinGuillaume BeinseJean-David FumetLaure FavierJulie NiogretBenoit BlanchetBernard RoyerLeïla Bengrine-LefevreAntonin Schmitt

Published in: Therapeutic advances in medical oncology (2024)

Based on real-world data, we were able to properly describe the time course of haemoglobinaemia and plasma creatininaemia during olaparib treatment.

Keyphrases

electronic health record
big data
machine learning
artificial intelligence
data analysis